Post-doctoral Training Fellow - Thoracic Oncology Immunotherapy Group

22/09/2019, 23:55

Cancer Therapeutics
Thor Onco Immuno Group
Full time
Fixed Term
Appointment will be on a Fixed Term Contract to 30/9/2022
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The group of Dr Astero Klampatsa is looking for a highly motivated Post-Doctoral Research Fellow to work in her group to create and characterise CAR-T cells against fibroblast-activating protein (FAP) and other targets. The work would involve the full range of techniques from cloning constructs to functional and toxicity testing on human cell lines and 3D spheroid models.

Candidates would need to have previous post-doctoral experience, a thorough understanding and experience of chimeric antigen receptor therapies, and have strong technical skills from performing mechanistic studies and projects. In addition, candidates will be required to have a Home Office Licence (1-4). Please refer to the attached job description and person-specification for full details.

The appointment will be on a Fixed Term Contract to 30/9/2022 in the first instance. Starting salary will be based on previous experience.

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates